CD4 and neoplasm: Along with disease prognosis, intratumoral levels of CD4+ and CD8+ T‐cells have been shown to directly impact the efficacy of chemotherapies in several tumor models.30 To ensure that we were not counting the immunosuppressive regulatory subset of the CD4+ T‐cells, we gated only the CD25low/CD4+ population.